HC

Health Catalyst, Inc.

HCATHealthcareNASDAQ

Health Information Services

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$311.1M
+1.5% YoY
Net Income
-$178.0M
-156.1% YoY
EBITDA
-$102.5M
-862.3% YoY
Free Cash Flow
-$48.6M

Scan Results

Daily timeframe
1 recent day hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Sep 3 MACD Positive CrossoverHistogram +0.0104, positive momentum
Sep 2 MACD Positive CrossoverHistogram +0.0036, positive momentum
About Health Catalyst, Inc.

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. At a $127.9M market cap, Health Catalyst, Inc. ranks as a micro-cap company within healthcare. The company operates in two segments: Technology and Professional Services.

Where HCAT stands vs its 150-day and 200-day moving averages

As of the September 3, 2026 close, HCAT finished 1.20% above its 150-day moving average ($1.67) and 9.14% below its 200-day moving average ($1.86). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is HCAT overbought or oversold?

At the September 3, 2026 close, HCAT's RSI(14) was 45.5, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$127.9M
Fwd P/E216.56
EPS$-3.65
Beta1.53
52W Change-48.2%
ROE-118.1%
Analysis

Health Catalyst, Inc. carries $170.0M in total debt against $103.4M in cash reserves — debt is roughly 1.6x the cash position. Managing this leverage effectively will be important for long-term financial stability. Free cash flow is running at -$48.6M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. ROE of -118.1% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has been uneven over recent years, ranging from $276.2M to $311.1M.

A beta of 1.53 means HCAT is more volatile than average. Investors should be prepared for wider price swings relative to broader indices. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Health Catalyst, Inc. and its sector.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms